Qyuns Therapeutics Co., Ltd. (HKG:2509)

Qyuns Therapeutics Statistics

Total Valuation

HKG:2509 has a market cap or net worth of HKD 4.64 billion. The enterprise value is 4.71 billion.

Market Cap	4.64B
Enterprise Value	4.71B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2509 has 224.57 million shares outstanding. The number of shares has increased by 4.05% in one year.

Current Share Class	224.57M
Shares Outstanding	224.57M
Shares Change (YoY)	+4.05%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	4.45%
Owned by Institutions (%)	13.96%
Float	106.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	18.20
PS Ratio	13.20
PB Ratio	19.60
P/TBV Ratio	18.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-22.40
EV / Sales	13.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-20.02

Financial Position

The company has a current ratio of 1.51, with a Debt / Equity ratio of 2.95.

Current Ratio	1.51
Quick Ratio	1.43
Debt / Equity	2.95
Debt / EBITDA	n/a
Debt / FCF	-2.96
Interest Coverage	-9.42

Financial Efficiency

Return on equity (ROE) is -68.26% and return on invested capital (ROIC) is -13.73%.

Return on Equity (ROE)	-68.26%
Return on Assets (ROA)	-10.67%
Return on Invested Capital (ROIC)	-13.73%
Return on Capital Employed (ROCE)	-27.65%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.04M
Profits Per Employee	-623,622
Employee Count	337
Asset Turnover	0.29
Inventory Turnover	4.05

Taxes

Income Tax	-79,992
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +173.68% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+173.68%
50-Day Moving Average	20.58
200-Day Moving Average	20.55
Relative Strength Index (RSI)	46.11
Average Volume (20 Days)	241,812

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2509 had revenue of HKD 351.04 million and -210.16 million in losses. Loss per share was -0.95.

Revenue	351.04M
Gross Profit	254.28M
Operating Income	-206.37M
Pretax Income	-216.48M
Net Income	-210.16M
EBITDA	-173.00M
EBIT	-206.37M
Loss Per Share	-0.95

Balance Sheet

The company has 612.43 million in cash and 696.84 million in debt, with a net cash position of -84.42 million or -0.38 per share.

Cash & Cash Equivalents	612.43M
Total Debt	696.84M
Net Cash	-84.42M
Net Cash Per Share	-0.38
Equity (Book Value)	236.50M
Book Value Per Share	1.12
Working Capital	249.86M

Cash Flow

In the last 12 months, operating cash flow was -231.22 million and capital expenditures -3.95 million, giving a free cash flow of -235.17 million.

Operating Cash Flow	-231.22M
Capital Expenditures	-3.95M
Free Cash Flow	-235.17M
FCF Per Share	-1.05

Margins

Gross margin is 72.44%, with operating and profit margins of -58.79% and -59.87%.

Gross Margin	72.44%
Operating Margin	-58.79%
Pretax Margin	-61.67%
Profit Margin	-59.87%
EBITDA Margin	-49.28%
EBIT Margin	-58.79%
FCF Margin	n/a

Dividends & Yields

HKG:2509 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.05%
Shareholder Yield	-4.05%
Earnings Yield	-4.53%
FCF Yield	-5.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2509 has an Altman Z-Score of 0.26 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.26
Piotroski F-Score	3